Peroxisomal acyl-CoA oxidase deficiency Advocacy Hub | UniteRare

At a Glance

Live from database

🔬

Regulatory Watchboard

3 events

Mar 2026OPDIVO: New indication approved

FDAcompleted

Apr 2023Treating Leg Symptoms in Women With X-linked Adrenoleukodystrophy

Massachusetts General Hospital — PHASE4

TrialACTIVE NOT RECRUITING

Jan 2012Longitudinal Natural History Study of Patients With Peroxisome Biogenesis Disorders (PBD)

McGill University Health Centre/Research Institute of the McGill University Health Centre

TrialRECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

1 program

FINANCIAL LANDSCAPE SUMMARY

Total programs

Open now

Patient Assistance Programs1

OPDIVO

E.R. Squibb & Sons, L.L.C.

OpenContact for detailsApply ↗

View all support programs on disease page →

Clinical Trial Landscape

2 active trials

1Phase 4

1Unknown

2Total recruiting

Search clinical trials for Peroxisomal acyl-CoA oxidase deficiency →

Recent News & Research

No recent news articles indexed yet for Peroxisomal acyl-CoA oxidase deficiency.
Search PubMed for Peroxisomal acyl-CoA oxidase deficiency →

Browse all Peroxisomal acyl-CoA oxidase deficiency news →

Specialist Network

Top 1 by expertise

Florian S Eichler, MD

Massachusetts General Hospital

📍 Boston, Massachusetts

Score 222 trials

View all Peroxisomal acyl-CoA oxidase deficiency specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰